Peter M. Castleman - 26 Feb 2026 Form 4 Insider Report for Caris Life Sciences, Inc. (CAI)

Reporting relationship: Director
Issuer ticker: CAI
Reported as of: 26 Feb 2026
Net transaction value: +$110,511
SEC form: 4
Accepted by SEC: 27 Feb 2026, 18:07:35 UTC
Prior SEC filing: 13 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Russel Denton, Attorney-in-Fact

Key filing fact

Peter M. Castleman filed Form 4 for Caris Life Sciences, Inc. (CAI) on 27 Feb 2026.

Key facts

This page summarizes Peter M. Castleman's Form 4 filing for Caris Life Sciences, Inc. (CAI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 27 Feb 2026, 18:07.

Change

Previous filing in this sequence was filed on 13 Jan 2026.
Current net transaction value: +$110,511.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001239594 Primary reporting owner

CASTLEMAN PETER M

Relationship: Director
Address: C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
Signature: /s/ J. Russel Denton, Attorney-in-Fact
Signature date: 27 Feb 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAI transaction

Common Stock

Award

Transaction value: $110,511
Shares: +5,509
Change %: +30%
Price: $20.06
Shares after: 24,138
Date: 26 Feb 2026
Ownership: Direct
Footnotes: F1

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 100,000
Date: 26 Feb 2026
Ownership: By Family Trust

CAI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,270,906
Date: 26 Feb 2026
Ownership: By CLS-PF-SPE, LLC
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Shares issued in lieu of cash compensation for 2025 board retainer fees. Number of shares determined by dividing the cash retainer earned by the ten trading day average of the daily volume weighted average price per share through and including February 25, 2026.

Footnote F2

CLS-PF-SPE Manager, LLC is the manager of CLS-PF-SPE, LLC. Mr. Castleman is a manager of CLS-PF-SPE Manager, LLC and in such capacity has voting and investment power with respect to the shares held by CLS-PF-SPE, LLC. The Reporting Person disclaims beneficial ownership except to the extent of his pecuniary interest therein.